Gravis G - Search Results

1

Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer.

Walz J, Marcy M, Pianna JT, Brunelle S, Gravis G, Salem N, Bladou F. Walz J, et al. Among authors: gravis g. World J Urol. 2011 Oct;29(5):589-94. doi: 10.1007/s00345-011-0688-x. Epub 2011 May 26. World J Urol. 2011. PMID: 21614469

2

Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study.

Salem N, Simonian-Sauve M, Rosello R, Alzieu C, Gravis G, Maraninchi D, Bladou F. Salem N, et al. Among authors: gravis g. Radiother Oncol. 2003 Feb;66(2):159-65. doi: 10.1016/s0167-8140(03)00004-5. Radiother Oncol. 2003. PMID: 12648787 Clinical Trial.

3

Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma.

Gravis G, Bladou F, Salem N, Macquart-Moulin G, Serment G, Camerlo J, Genre D, Bardou VJ, Maraninchi D, Viens P. Gravis G, et al. Cancer. 2003 Oct 15;98(8):1627-34. doi: 10.1002/cncr.11687. Cancer. 2003. PMID: 14534878 Free article.

4

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. George L, et al. Among authors: gravis g. Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.

5

[Permanent iodine 125 implant brachytherapy in localized prostate cancer: results of the first 4 years of experience].

Bladou F, Salem N, Simonian-Sauve M, Rosello R, Ternier F, Resbeut M, Alzieu C, Karsenty G, Serment G, Gravis G, Maraninchi D. Bladou F, et al. Among authors: gravis g. Prog Urol. 2004 Jun;14(3):345-52. Prog Urol. 2004. PMID: 15373176 French.

6

Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer.

Guedea F, Aguilo F, Polo A, Langley S, Laing R, Henderson A, Aaltomaa S, Kataja V, Palmgren J, Bladou F, Salem N, Gravis G, Losa A, Guazzoni G, Nava L. Guedea F, et al. Among authors: gravis g. Radiother Oncol. 2006 Jul;80(1):57-61. doi: 10.1016/j.radonc.2006.06.004. Epub 2006 Jul 10. Radiother Oncol. 2006. PMID: 16831480

7

FGFR1 and WT1 are markers of human prostate cancer progression.

Devilard E, Bladou F, Ramuz O, Karsenty G, Dalès JP, Gravis G, Nguyen C, Bertucci F, Xerri L, Birnbaum D. Devilard E, et al. Among authors: gravis g. BMC Cancer. 2006 Nov 30;6:272. doi: 10.1186/1471-2407-6-272. BMC Cancer. 2006. PMID: 17137506 Free PMC article.

8

[Prostate cancer and chemotherapy].

Gravis G, Salem N, Bladou F, Viens P. Gravis G, et al. Bull Cancer. 2007 Jul;94(7 Suppl):F21-8. Bull Cancer. 2007. PMID: 17845990 Review. French.

9

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

Walz J, Bladou F, Rousseau B, Laroche J, Salem N, Gravis G, Briganti A, Chun FK, Karakiewicz PI, Fournier G. Walz J, et al. Among authors: gravis g. Urology. 2012 Mar;79(3):546-51. doi: 10.1016/j.urology.2011.11.036. Urology. 2012. PMID: 22386393

10

Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up.

Guerin M, Salem N, Walz J, Dermeche S, Gravis G. Guerin M, et al. Among authors: gravis g. World J Surg Oncol. 2013 Sep 27;11:243. doi: 10.1186/1477-7819-11-243. World J Surg Oncol. 2013. PMID: 24073932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters